The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Sphingosine 1-Phosphate Receptor Signaling
Abstract
The sphingosine 1-phosphate (S1P) receptor signaling system is a productive model system. A hydrophobic zwitterionic lysophospholipid ligand with difficult physical properties interacts with five high-affinity G protein–coupled receptors to generate multiple downstream signals. These signals modulate homeostasis and pathology on a steep agonist concentration-response curve. Ligand presence is essential for vascular development and endothelial integrity, while acute increases in ligand concentrations result in cardiac death. Understanding this integrated biochemical system has exemplified the impact of both genetics and chemistry. Developing specific tools with defined biochemical properties for the reversible modulation of signals in real time has been essential to complement insights gained from genetic approaches that may be irreversible and compensated. Despite its knife-edge between life and death, this system, based in part on receptor subtype-selectivity and in part on differential attenuation of deleterious signals, now appears to be on the cusp of meaningful therapy for multiple sclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early studies of primary bile acids have been shown to exert direct negative myocardial chronotropic effects in a dose-dependent fashion132,133.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [132]
In the citing paper
“Though at lower concentrations relative to primary bile acids even in cholestatic states, secondary bile acids can also exert similar effects.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [132]
Citations
Cites
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,411
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Kühn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,280
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,115
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
MANDALA, S. M., Hajdu, R., Bergstrom, J. D., Quackenbush, E. J., Xie, J., Milligan, J. A., Thornton, R. A., Shei, G.-J., Card, D., Keohane, C.-A., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,691
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E. E., Baumruker, T., HIESTAND, P. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,512
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,335
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,165
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J. P., Comi, G., Montalbán, X., O'Connor, P. W., Polman, C. H., Haas, T., Korn, A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,058
Research works printed but not linked: 6
- Clair T, 2003, Cancer Res., 63, 5446
- 10.1042/0264-6021:3520809 · DOI
- Chiba K, 2006, Cell Mol. Immunol., 3, 11
- Suzuki S, 1998, Transplant. Int., 11, 95
- Suzuki S, 1996, Transplant. Proc., 28, 2049
- Merrill AH, 2007, Naunyn-Schmiedebergs Arch. Pharmacol., 374, 321
Cited by
Sorted by citations
Items 301–400 of 424
Shao, X., Liu, K., Fan, Y., Ding, Z., Chen, M., Zhu, M., Weinstein, L. S., Li, H., & Li, H. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.08.006 · Cited by 9
Lee, K. P., Baek, S., Jung, S. H., Cui, L., Lee, D., Lee, D.-Y., Choi, W. S., Chung, H. W., Lee, B. H., Kim, B., et al. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2132-1 · Cited by 9
Yet, L. (2018) · doi:10.1002/9781118686263.ch10 · Cited by 9
Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models
Hendek, H. H., Blusch, A., Heitmann, N., Oberhagemann, S., Demir, S., Pedreiturria, X., Gold, R., & Faissner, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-68715-x · Cited by 8
Locomotor and histological changes in a cuprizone-induced animal model of multiple sclerosis
Mitra, N. K., Singh, N. S. A. L. G., Wadingasafi, N. A. N. B., & Chellian, J. (2022) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.335172 · Cited by 8
Reece, A. S. (2012) · Substance Abuse Research and Treatment · doi:10.4137/sart.s9031 · Cited by 8
Xiao, Q., Jin, J., Wang, X., Hu, J., Xi, M., Tian, Y., & Yin, D. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.059 · Cited by 8
Development of a Suitable Physical Form for a Sphingosine-1-phosphate Receptor Agonist
Morrison, H. G., Burke, B. J., Lei, D., Robertson, V. K., Nagapudi, K., Chan, J., Gore, A., Fang, J., & Jona, J. (2011) · Organic Process Research & Development · doi:10.1021/op200192n · Cited by 8
Zhang, L., Okada, T., Badawy, S. M. M., Hirai, C., Kajimoto, T., & Nakamura, S. (2018) · Scientific Reports · doi:10.1038/srep46964 · Cited by 8
Sphingosine 1-Phosphate Lyase in the Developing and Injured Nervous System: a Dichotomy?
Xiao, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03524-3 · Cited by 8
Structural Biology of the S1P1 Receptor
Hanson, M. A., & Peach, R. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-05879-5_2 · Cited by 7
Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors
Kharel, Y., Huang, T., Santos, W. L., & Lynch, K. R. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.07.001 · Cited by 7
Cytoskeletal Dynamics and Lung Fluid Balance
Vogel, S. M., & Malik, A. B. (2012) · Comprehensive physiology · doi:10.1002/j.2040-4603.2012.tb00395.x · Cited by 7
Sphingolipids: A Potential Molecular Approach to Treat Allergic Inflammation
Sun, W. Y., & Bonder, C. S. (2012) · Journal of Allergy · doi:10.1155/2012/154174 · Cited by 9
Impact of Age and Polytherapy on Fingolimod Induced Bradycardia: a Preclinical Study
Ritter, C., Svačina, M. K. R., Bobylev, I., Joshi, A. R., Schneider, T., & Lehmann, H. C. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9727-8 · Cited by 7
Measuring Sphingosine-1-Phosphate/Protein Interactions with the Kinetic Exclusion Assay
Fleming, J. K., & Wojciak, J. M. (2017) · Methods in molecular biology · doi:10.1007/7651_2017_5 · Cited by 7
Okada, T., Nishida, S., Zhang, L., Mohamed, N. N. I., Wang, T., Ijuin, T., Kajimoto, T., & Nakamura, S. (2021) · iScience · doi:10.1016/j.isci.2021.103351 · Cited by 6
Jing, X., Wang, J., Yin, W., Li, G., Fang, Z., Zhu, W., Guo, F., & Ye, Y. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3734 · Cited by 6
Kim, E., Cho, H.-K., Lim, C., Lee, J., Lee, D., Kim, S., & Moon, A. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.05.006 · Cited by 6
Dash, R. P., Srinivas, N. R., & Rais, R. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4109 · Cited by 6
Wang, X., Sun, C., Fang, L., & Yin, D. (2014) · MedChemComm · doi:10.1039/c4md00312h · Cited by 5
Kim, E., Kim, S., & Moon, A. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.030411 · Cited by 5
Xu, H., McElvain, M. E., Fiorino, M., Henkle, B., Sherman, L., Xu, Y., Tominey, E., Kelley, K. W., Adlam, M. J., Bürli, R. W., et al. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113488629 · Cited by 5
Wu, K., Liang, Q., Ding, N., Li, B., & Hao, J. (2020) · Bioscience Reports · doi:10.1042/bsr20200157 · Cited by 6
Oldstone, M. B. A., Hodder, P., Crisp, M., Roberts, E., Guerrero, M. A., Urbano, M., Velaparthi, S., Zhao, J., Rosen, H., Schaeffer, M., et al. (2010) · Europe PMC (PubMed Central) · Cited by 5
Self-citationAl‐Jarallah, A., & Oriowo, M. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170792 · Cited by 5
Olson, A. D., Hartung, J. P., Timony, G. A., Peach, R., Boehm, M. F., Rosen, H., Smith, H., Pan, C., Brooks, J. L., & Gujrathi, S. (2013) · Neurology · doi:10.1212/wnl.80.7_supplement.p01.178 · Cited by 5
Self-citationS1PR2 Signaling in the Lung: Understanding Its Role in Health and Disease
Ha, A. W., Garcia, J. G. N., & Dudek, S. M. (2025) · Cells · doi:10.3390/cells15010010 · Cited by 4
The Role of Sphingosine 1-Phosphate Receptors In the Treatment of Demyelinating Diseases
Pritchard, A. J., & Dev, K. K. (2013) · Future Neurology · doi:10.2217/fnl.13.32 · Cited by 4
The influence of Arhgef1 on pulmonary leukocyte function
Guan, Y., Torres, R. M., & Hartney, J. M. (2012) · Immunologic Research · doi:10.1007/s12026-012-8360-0 · Cited by 4
Barrier stabilizing mediators in regulation of microvascular endothelial permeability.
Huang, Q. (2012) · PubMed Central · doi:10.3760/cma.j.issn.1008-1275.2012.02.008 · Cited by 4
Talmont, F., Mitri, E., Dozier, C., Besson, A., Cuvillier, O., & Hatzoglou, A. (2022) · Cancers · doi:10.3390/cancers14071661 · Cited by 4
Sphingolipids: From structural components to signaling hubs
Issleny, B. M., Jamjoum, R., Majumder, S., & Stiban, J. (2023) · The Enzymes · doi:10.1016/bs.enz.2023.07.003 · Cited by 4
Zhang, Z., & Zhao, C. (2013) · InTech eBooks · doi:10.5772/53308 · Cited by 5
Identification of a Novel Agonist of the Sphingosine 1-phosphate Receptor 4 (S1P4)
Guerrero, M. A., Urbano, M., Velaparthi, S., Schaeffer, M., Brown, S. J., Crisp, M., Ferguson, J., Hodder, P., Rosen, H., Oldstone, M. B. A., et al. (2010) · Europe PMC (PubMed Central) · Cited by 4
Self-citationHamilton, P. J., Chen, E. Y., Tolstikov, V., Peña, C. J., Shah, P., Panagopoulos, K., Strat, A. N., Walker, D. M., Lorsch, Z. S., Mervosh, N. L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/490748 · Cited by 4
Visualizing S1P-directed cellular egress by intravital imaging
Giannouli, C. C., Chandris, P., & Proia, R. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.09.012 · Cited by 3
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus
Radin, M., Cecchi, I., Schreiber, K. I., Baldovino, S., Rossi, D., Menegatti, E., Roccatello, D., & Sciascia, S. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1257937 · Cited by 3
Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis
Kuczynski, A. M., & Oh, J. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2021-0005 · Cited by 3
3D-QSAR Studies on Thiazolidin-4-one S1P1 Receptor Agonists by CoMFA and CoMSIA
Qian, C., Zheng, J., Xiao, G., Guo, J., Yang, Z., Huang, L., Chao, W., Rao, L., & Sun, P. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12106502 · Cited by 3
Brooks, J. L., Peach, R., Boehm, M. F., Brahmachary, E., Clemons, B., Dedman, H., Desale, H., Gujrathi, S., Huang, L., Hartung, J. P., et al. (2013) · Gastroenterology · doi:10.1016/s0016-5085(13)60827-6 · Cited by 3
Self-citationRokitta, S. D. (2012) · Helmholtz-Zentrum für Polar-und Meeresforschung (Alfred-Wegener-Institut) · Cited by 3
Nishida, S., Matovelo, S. A., Kajimoto, T., Nakamura, S., & Okada, T. (2024) · Communications Biology · doi:10.1038/s42003-024-06828-9 · Cited by 4
Rosen, H., & Roberts, E. (2024) · Advances in pharmacology · doi:10.1016/bs.apha.2024.10.003 · Cited by 2
Self-citationAn efficient method for preparing the sphingosine-1-phosphate receptor agonist, KRP203-phosphate
Wang, X., Qi, J., Li, G., Tian, Y., & Yin, D. (2013) · Chinese Chemical Letters · doi:10.1016/j.cclet.2013.05.016 · Cited by 2
Omotuyi, O. I., & Ueda, H. (2015) · HAL · Cited by 2
SPHINGOLIPID VARIETY, BIOSYNTHESIS AND REGULATION
Faure, J., & Molino, D. (2015) · HAL · Cited by 2
S1PR2 deficiency enhances neuropathic pain induced by partial sciatic nerve ligation
Qiang, G. U., & Hou, J. (2019) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1710-77 · Cited by 2
Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
D’Amico, F., Roda, G., Peyrin‐Biroulet, L., & Danese, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190307165703 · Cited by 2
Xiao, Q., Hu, M., Chen, S., Shi, Z., Hu, J., Xie, P., & Yin, D. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115722 · Cited by 2
Role of the Microbiome in Cardiovascular Disease
Chaikijurajai, T., Wilcox, J. D., & Tang, W. H. W. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_15 · Cited by 2
Watanabe, M., Sato, T., Umetsu, A., Ogawa, T., Nishikiori, N., Suzuki, M., Furuhashi, M., & Ohguro, H. (2024) · Biomedicines · doi:10.3390/biomedicines12061165 · Cited by 2
Yet, L. (2018) · Wiley eBooks · doi:10.1002/9781118686263.ch5 · Cited by 2
Nishida, S., Matovelo, S. A., Kajimoto, T., Nakamura, S., & Okada, T. (2024) · Genes to Cells · doi:10.1111/gtc.13093 · Cited by 1
Kaur, P., Karuppuchamy, T., Chilukuri, A., Kim, M., Urrete, J., Shen, Z., Saxon, L., Lundborg, L. R., Mikulski, Z., Jedlicka, P., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf030 · Cited by 1
Yuan, H., Xie, Z., Feng, M., Jianying, Z., Geng, R., Zhou, C., Lao, Q., & Huang, X. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000546571 · Cited by 1
Liu, M., Li, Y., Wang, S., Gao, T., Song, Y., Li, L., Meng, M., & Yang, K. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144006 · Cited by 1
Design, synthesis, and biological evaluation of sphingosine kinase 2 inhibitors derived from K145
Liu, J., Shi, X., Yang, X., Zhao, X., Huang, F., Li, Z., Liu, Y., Gao, Y., Feng, J., Qu, Z., et al. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130667 · Cited by 1
Sylvain, G., Zhao, C., & Maria, J. (2012) · InTech eBooks · doi:10.5772/26708
Yang, S., Hu, J., & Li, Y. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.11.005 · Cited by 1
Yang, S., Hu, J., Li, Y., & Zhao, Z. (2018) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2161 · Cited by 1
Xiao, Q., Hu, M., Chen, S., Jin, J., Li, L., Hu, J., Xie, P., & Yin, D. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127141 · Cited by 1
Sphingosine Kinases: Biochemistry, Regulation, and Roles
Pitman, M. R., Jarman, K. E., Leclercq, T. M., Pham, D., & Pitson, S. M. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch9 · Cited by 1
Sphingosine 1‐Phosphate (S1P) Receptors
Jung, B., & Hla, T. (2013) · doi:10.1002/9781118531426.ch2 · Cited by 1
Xiao, L. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.105357 · Cited by 1
Sphingosine-1-phosphate as a mediator of endothelial dysfunction during inflammation
Levkau, B. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0168-9_7
Sphingosine 1‐Phosphate (S1P) Signaling in Cardiovascular Physiology and Disease
Levkau, B. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch14
Huang, J., Wang, X., & Chan, J. (2013) · Wiley eBooks · doi:10.1002/9781118354520.ch12
SEQUENTIAL DELIVERY OF ANGIOGENIC GROWTH FACTORS FROM POROUS HOLLOW FIBER MEMBRANES
Tengood, J. E. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
How Ca2+is Regulated Inside Cells
Campbell, A. K. (2014) · Wiley eBooks · doi:10.1002/9781118675410.ch5
Sphingosine 1‐Phosphate (S1P) Signaling and Lymphocyte Egress
Mendoza, A., Pitt, L. A., & Schwab, S. R. (2013) · doi:10.1002/9781118531426.ch22
S1P receptor agonists, a novel generation of immunosuppressants
Almagro, R. L., Tarrasón, G., & Godessart, N. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.018
Japtok, L. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17290
Einfluss von FTY720, S1P und Estrogen auf die Tumorpromotion
Potteck, H. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-12456
On the stimulatory effect of microglial cells on angiogenesis
Rymo, S. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)
The role of N-cadherin and S1P/S1P1 in pancreas development
Johansson, J. K. (2010) · Lund University Publications (Lund University)
Yang, Y., & Uhlig, S. (2011) · RWTH Publications (RWTH Aachen)
Murakami, A., Takasugi, H., Ohnuma, S., Koide, Y., Sakurai, A., Takeda, S., Hasegawa, T., Sasamori, J., Konno, T., Hayashi, K., et al. (2010)
Ray, A., & Srivastava, P. (2011) · CRC Press eBooks · doi:10.1201/b11483-3
Endothelial cell signalling of APC and thrombin : the involvement of protein kinase C
Yu, Y. (2012) · Spiral (Imperial College London) · doi:10.25560/18048
Shilpi, S., Reddy, K., & Puneet Kumar, B. (2017)
Li, C. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2060
The Effects Of Bone Marrow Adipocytes On Metabolic Regulation In Metastatic Prostate Cancer
Diedrich, J. D. (2017) · Human Biology
Sphingosine 1‐Phosphate Signalling
Bernacchioni, C., Cencetti, F., Donati, C., & Bruni, P. (2019) · Wiley eBooks · doi:10.1002/9780470015902.a0028300
Szymaszkiewicz, K., Szymaszkiewicz, A., & Fichna, J. (2020) · Postępy Biochemii · doi:10.18388/pb.2020_310
Le, T. N. U., Nguyen, Q. T., Nguyen, Y. T. K., Tan, C. K. H., Tukijan, F., Couty, L., Hasan, Z., Kalailingam, P., Wenk, M. R., Cazenave‐Gassiot, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.15.468739
Alpha-synuclein spreading mechanisms in Parkinson's disease: The role of membrane receptors
Brás, I. C., & Outeiro, T. F. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.002
Bradley, L. M., & Baaten, B. J. G. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13353033.14724155
Giancotti, F. G. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717956665.793461260
(2014) · Wiley eBooks · doi:10.1002/9781118675410.biblio
Yet, L. (2018) · doi:10.1002/9781118686263.ch8
Translational pharmacology and biomarkers applied to GPCR
Özcelik, D., Andreetta, F., & van der Kam, E. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00036-4
Role of S1PR1 in Modulating Airway Epithelial Responses to Pseudomonas aeruginosa in Cystic Fibrosis
Cigana, C., Caslini, C., Migliara, A., Alcalá-Franco, B., Veschetti, L., Lorè, N. I., Lombardo, A., & Bragonzi, A. (2025) · Pathogens · doi:10.3390/pathogens14111146
Sphingosine-1-phosphate effects on conventional outflow physiology
Sumida, G. M. (2010) · UA Campus Repository (The University of Arizona)
Combination Strategies for Stem Cell Mobilization Targeting CXCR4 and S1P Receptors
Harun, N., Bradstock, K. F., & Bendall, L. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1960-0_3
Metadata
- Authors
- Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G., & Brown, S.
- Affiliations
- Scripps Research Institute (US)
- Departments of Chemical Physiology and Immunology and The Scripps Research Institute Molecular Screening Center, The Scripps Research Institute, La Jolla, California 92037;
- Venue
- Annual Review of Biochemistry
- Publisher
- Annual Reviews
- Published
- 2009-06-01
- Volume
- 78
- Issue
- 1
- Pages
- 743-768
- ISSN
- 0066-4154 (ISSN-L)
- 1545-4509
- OpenAlex
- W2127032203
- Cited by
- 404
- References
- 151
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 8 · 2023: 10 · 2022: 12 · 2021: 19 · 2020: 17 · 2019: 18 · 2018: 29 · 2017: 27 · 2016: 28 · 2015: 21 · 2014: 27 · 2013: 48 · 2012: 50
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, receptor signaling, vascular development, endothelial integrity, cardiovascular mortality, signal attenuation, receptor subtype selectivity, multiple sclerosis treatment
- MeSH terms
- Animals, Cardiovascular System, Humans, Lymphoid Tissue, Multiple Sclerosis, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review